- Home
- THW vs DCTH Comparison
THW vs DCTH Comparison
Compare THW & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- DCTH
- Stock Information
- Founded
- THW 2015
- DCTH 1988
- Country
- THW United States
- DCTH United States
- Employees
- THW N/A
- DCTH N/A
- Industry
- THW Finance Companies
- DCTH Medical/Dental Instruments
- Sector
- THW Finance
- DCTH Health Care
- Exchange
- THW Nasdaq
- DCTH Nasdaq
- Market Cap
- THW 454.0M
- DCTH 518.0M
- IPO Year
- THW N/A
- DCTH N/A
- Fundamental
- Price
- THW $11.32
- DCTH $12.57
- Analyst Decision
- THW
- DCTH Strong Buy
- Analyst Count
- THW 0
- DCTH 4
- Target Price
- THW N/A
- DCTH $22.75
- AVG Volume (30 Days)
- THW 149.9K
- DCTH 485.6K
- Earning Date
- THW 01-01-0001
- DCTH 03-06-2025
- Dividend Yield
- THW 10.76%
- DCTH N/A
- EPS Growth
- THW N/A
- DCTH N/A
- EPS
- THW N/A
- DCTH N/A
- Revenue
- THW N/A
- DCTH $37,205,000.00
- Revenue This Year
- THW N/A
- DCTH $112.81
- Revenue Next Year
- THW N/A
- DCTH $61.78
- P/E Ratio
- THW N/A
- DCTH N/A
- Revenue Growth
- THW N/A
- DCTH 1701.69
- 52 Week Low
- THW $9.76
- DCTH $4.26
- 52 Week High
- THW $14.89
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- THW 29.90
- DCTH 39.92
- Support Level
- THW $11.80
- DCTH $11.11
- Resistance Level
- THW $12.03
- DCTH $14.61
- Average True Range (ATR)
- THW 0.13
- DCTH 0.74
- MACD
- THW -0.05
- DCTH -0.01
- Stochastic Oscillator
- THW 1.39
- DCTH 27.40
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.